Acta Cardiologica

Aims & Scope

Acta Cardiologica is an international journal.

It publishes bi-monthly original, peer-reviewed articles on all aspects of cardiovascular disease including observational studies, clinical trials, experimental investigations with clear clinical relevance and tutorials.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5

Journal Rank

Year	Value
2024	14981

Journal Citation Indicator

Year	Value
2024	559

SJR (SCImago Journal Rank)

Year	Value
2024	0.356

Quartile

Year	Value
2024	Q3

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• C-reactive protein and paroxysmal atrial fibrillation

  Citation: 156

  Authors: John, Maria

• Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction

  Citation: 133

  Authors: Pieter, Petra, Frederik H., Kevin, Matthias, Wilfried

• Endothelial dysfunction in hypertension

  Citation: 118

  Authors: Paolo, Giovanni M., Fabio, Antonio

• Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control

  Citation: 110

  Authors: Nizal, Gholamhosein, Hosein, Mehdi, Nooshin, Shahnaz, Hamidreza, Masoud, Masoumeh, Aliakbar, Morteza, Roya, Katayoun, Nasrollah, Maryam, Sedigheh, Gholamali, Tahereh, Alireza

• Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity

  Citation: 104

  Authors:

• Beta-blockers: focus on mechanism of action Which beta-blocker, when and why?

  Citation: 95

  Authors: Frauke, Hans

• Cardiovascular function and basics of physiology in microgravity

  Citation: 91

  Authors: André E., Frank, Bart

• Slow coronary flow may be a sign o diffuse atherosclerosis

  Citation: 89

  Authors: Hasan, V. Gökhan, Dilek, Ahmet, Necdet, Oben, H. Tuncay

• Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload

  Citation: 77

  Authors: Frederik, Matthias, Philippe, Petra, Joris, Joseph, David, Pieter, W, Wilfried

• Management and outcomes of Middle Eastern patients admitted with acute coronary syndromes in the Gulf Registry of Acute Coronary Events (Gulf RACE)

  Citation: 75

  Authors:

---